CC
PFE icon

Climber Capital’s Pfizer PFE Stock Holding History

Climber Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,350
Closed -$543K – 68
2026
Q1 		$543K Buy
+19,350
New +$515K 0.36% 54

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Climber Capital's PFE Position: Q2 2026 in Review

Climber Capital sold out of Pfizer (PFE) in Q2 2026, closing a stake of 19,350 shares — an estimated $543K sold.

Climber Capital first reported a position in PFE in Q1 2026 and held it in 1 quarter. The position peaked at $543K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Climber Capital reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Climber Capital sold 19,350 Pfizer shares in Q2 2026, an estimated $543K.
  • Climber Capital first reported a position in Pfizer in Q1 2026 and held it in 1 quarter.
  • Climber Capital's Pfizer position peaked at $543K in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Climber Capital's 13F filing for Q2 2026, filed 22 Jul 2026.